Cellectis (CLLS) Notes Payables (2014 - 2022)
Cellectis (CLLS) posted quarterly Notes Payables of $2.1 million for Q1 2016, down 0.68% quarter-over-quarter from $2.1 million in Q4 2015.
Analysis
Cellectis (CLLS) Notes Payables (2014 - 2022) Analysis & Trends
Cellectis' Notes Payables history runs 3 years deep, the most recent figure standing at $2.1 million for Q1 2016.
- In Q1 2016, Notes Payables changed N/A year-over-year to $2.1 million; the TTM figure through Mar 2016 stood at $2.1 million (changed N/A YoY), while the FY2015 annual figure was $2.1 million, up 86.22% from the prior year.
- Notes Payables for Q1 2016 stood at $2.1 million, down from $2.1 million in the prior quarter.
- The five-year high for Notes Payables was $3.3 million in Q3 2015, with the low at $3350.8 in Q2 2015.
- The 3-year median for Notes Payables is $2.1 million (2016), against an average of $1.7 million.
- Peak annual rise in Notes Payables reached 95.45% in 2015, while the deepest fall reached 95.45% in 2015.
- Cellectis' Notes Payables stood at $1.1 million in 2014, then soared by 95.45% to $2.1 million in 2015, then decreased by 0.68% to $2.1 million in 2016.
- Business Quant data shows CLLS's Notes Payables at $2.1 million in Q1 2016, $2.1 million in Q4 2015, and $3.3 million in Q3 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 175,000.00 |
| Mar 31, 2022 | 64,000.00 |
| Dec 31, 2021 | 172,000.00 |
| Mar 31, 2016 | 2.09 Mn |
| Dec 31, 2015 | 2.11 Mn |
| Sep 30, 2015 | 3.32 Mn |
| Jun 30, 2015 | 3.35 Mn |
| Dec 31, 2014 | 1.08 Mn |